Since a downregulation of survivin correlates with RA exposure [41] and micronuclei formation in cancer cell lines [42], we decided to investigate whether survivin expression could also be reduced in embryonic stem cells undergoing neurogenesis after treatment with RA. This evidence concerns the gene BIRC5 and cancer.